Physician profile
Steven T Thaxter
NPI 1760465496
$37,973.03
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $131 · 2021: $311 · 2022: $3,906 · 2023: $117 · 2024: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Travel and Lodging: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.76 |
| Travel and Lodging | $861.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $29,402.65 | 2019 | |
| Arthrex, INC. | $3,456.70 | 2019-2024 | |
| Sequoia Surgical, INC. | $2,348.92 | 2019-2022 | |
| Cornerstone Medical Associates, INC. | $2,003.19 | 2022-2024 | |
| Lima USA, INC. | $286.77 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $241.81 | 2019 | |
| Medtronic USA, INC. | $137.56 | 2019 | |
| Depuy Synthes Sales INC. | $55.92 | 2023 | Vapr, Truespan Orthocord, Rigidloop |
| Ferring Pharmaceuticals INC. | $39.51 | 2019-2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$350,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Thaxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.